Crossref
SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence
Clinical Diabetology · 2026-04-28
DOI: 10.5603/cd.112125 ↗At a glance
Journal article in Clinical Diabetology, published online on 2026-04-28. Written by Jacek Kubica and 1 co-authors.
Abstract (original language)
Není k dispozici žádný abstrakt.
Cite
APA
Kubica, J., & Kubica, A. (2026). SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. https://doi.org/10.5603/cd.112125
Vancouver
Kubica J, Kubica A. SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence. Clinical Diabetology. 2026. doi:10.5603/cd.112125
BibTeX
@article{Kubica2026,
author = {Kubica, Jacek and Kubica, Aldona},
title = {SGLT2 Inhibitors in Kidney Transplant Recipients: Promising Signals, But Limited Evidence},
journal = {Clinical Diabetology},
year = {2026},
doi = {10.5603/cd.112125}
}
EUVIMED